Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,063 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Follow-Up Questions
What is Hologic Inc (HOLX)'s P/E Ratio?
The P/E ratio of Hologic Inc is 18.419
Who is the CEO of Hologic Inc?
Mr. Stephen Macmillan is the Chairman of the Board of Hologic Inc, joining the firm since 2013.
What is the price performance of HOLX stock?
The current price of HOLX is $74.07, it has decreased 0.04% in the last trading day.
What are the primary business themes or industries for Hologic Inc?
Hologic Inc belongs to Health Care industry and the sector is Health Care
What is Hologic Inc market cap?
Hologic Inc's current market cap is $16.4B
Is Hologic Inc a buy, sell, or hold?
According to wall street analysts, 17 analysts have made analyst ratings for Hologic Inc, including 6 strong buy, 8 buy, 13 hold, 1 sell, and 6 strong sell
